CU20140145A7 - Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae - Google Patents

Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae

Info

Publication number
CU20140145A7
CU20140145A7 CU2014000145A CU20140145A CU20140145A7 CU 20140145 A7 CU20140145 A7 CU 20140145A7 CU 2014000145 A CU2014000145 A CU 2014000145A CU 20140145 A CU20140145 A CU 20140145A CU 20140145 A7 CU20140145 A7 CU 20140145A7
Authority
CU
Cuba
Prior art keywords
streptococcus pneumoniae
pneumoniae
chemeric
vaccine
vaccine against
Prior art date
Application number
CU2014000145A
Other languages
English (en)
Other versions
CU24238B1 (es
Inventor
Aleksandr Nikolaevich Suvorov
Llya Vladimirovich Dukhovlinov
Anton Losifovich Orlov
Evgenii Jakovlevich Baiguzin
Original Assignee
Epitope Ltd Epitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitope Ltd Epitope Ltd filed Critical Epitope Ltd Epitope Ltd
Publication of CU20140145A7 publication Critical patent/CU20140145A7/es
Publication of CU24238B1 publication Critical patent/CU24238B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

El problema a resolver: ausencia de una vacuna eficiente segura para la profilaxis y el tratamiento de enfermedades causadas por Streptococcus pneumoniae (S.pneumoniae) capaz de proporcionar defensa contra todas las cepas de S.pneumoniae (ausencia de una vacuna universal contra neumococos). La solución: Se da la vacuna basada en la proteína quimérica que consiste en epítopos inmunogénicos de proteínas conservadoras de Streptococcus pneumoniae: PspA, Spr1895, y PsaA, así como también los componentes de la flagellina (FliC1, FliC2) que funciona como un adyuvante seguro, y en consecuencia las proteínas o los péptidos homólogos a aquellos no menos que el 60% se sus secuencias de aminoácidos, conectadas a través de uniones flexibles. Se muestran seguridad, eficacia y ambos efectos preventivos y terapéuticos.
CUP2014000145A 2012-06-22 2013-06-21 Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae CU24238B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012126328/15A RU2510281C2 (ru) 2012-06-22 2012-06-22 ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
PCT/RU2013/000525 WO2013191591A1 (en) 2012-06-22 2013-06-21 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
CU20140145A7 true CU20140145A7 (es) 2015-04-29
CU24238B1 CU24238B1 (es) 2017-02-02

Family

ID=49769080

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2014000145A CU24238B1 (es) 2012-06-22 2013-06-21 Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae

Country Status (12)

Country Link
US (1) US9345757B2 (es)
EP (1) EP2863944B1 (es)
JP (1) JP6195089B2 (es)
KR (1) KR20150034192A (es)
CN (1) CN104470538B (es)
BR (1) BR112014032135A2 (es)
CU (1) CU24238B1 (es)
EA (1) EA027981B1 (es)
MX (1) MX355642B (es)
RU (1) RU2510281C2 (es)
UA (1) UA116634C2 (es)
WO (1) WO2013191591A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104844712B (zh) * 2015-04-03 2019-06-28 长春百克生物科技股份公司 肺炎链球菌蛋白抗原及其制备方法和应用
RU2591809C1 (ru) * 2015-07-21 2016-07-20 Андрей Дмитриевич Протасов Способ активации факторов противовирусной защиты у пациентов с хронической обструктивной болезнью легких
RU2627602C2 (ru) * 2015-12-29 2017-08-09 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ получения химерного рекомбинантного белка fliC:pagN
US11806392B2 (en) 2016-12-03 2023-11-07 The Uab Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
HUE065959T2 (hu) * 2017-08-03 2024-07-28 Intervet Int Bv Vakcina Streptococcus suis elleni védelemre
RU2687488C1 (ru) * 2018-07-12 2019-05-14 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" ФГБНУ ВНИТИБП Формолвакцина полиштаммная против пневмоний телят стрептококковой этиологии
RU2720614C9 (ru) * 2020-04-23 2021-02-09 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Иммунобиологическое средство и способ его использования для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 (варианты)
CN120192426B (zh) * 2025-03-04 2025-11-11 江西澄实生物科技有限公司 一种预防沙门氏菌感染的疫苗及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
JP2003519089A (ja) * 1999-06-10 2003-06-17 ユーエイビー リサーチ ファウンデーション 肺炎球菌表面型蛋白質配合ワクチン
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
CN1636062A (zh) 2001-04-16 2005-07-06 惠氏控股公司 编码多肽抗原的新肺炎链球菌可读框及其应用
EP2333114A1 (en) 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigens
EP1477802A1 (en) 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
EP2371843B1 (en) 2005-05-19 2014-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
BRPI0620460B8 (pt) * 2005-12-22 2021-05-25 Glaxosmithkline Biologicals Sa uso de composição imunogênica para bebês, e, processo para produzir uma vacina
CA2728038A1 (en) * 2008-06-25 2009-12-30 Inserm (Institut National De La Sante Et De La Recherche Medicale) Novel immunoadjuvant flagellin-based compounds and use thereof
WO2010045620A1 (en) * 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US8003112B2 (en) 2009-04-16 2011-08-23 Howard University Meningococcal and pneumococcal conjugate vaccine and method of using same
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same

Also Published As

Publication number Publication date
RU2510281C2 (ru) 2014-03-27
US9345757B2 (en) 2016-05-24
HK1208632A1 (en) 2016-03-11
MX355642B (es) 2018-04-25
CU24238B1 (es) 2017-02-02
MX2014016049A (es) 2015-07-06
EP2863944B1 (en) 2018-12-19
EP2863944A1 (en) 2015-04-29
EP2863944A4 (en) 2016-05-11
BR112014032135A2 (pt) 2017-08-01
WO2013191591A1 (en) 2013-12-27
JP6195089B2 (ja) 2017-09-20
US20150174230A1 (en) 2015-06-25
CN104470538A (zh) 2015-03-25
WO2013191591A4 (en) 2014-04-03
RU2012126328A (ru) 2013-12-27
WO2013191591A9 (en) 2014-02-13
UA116634C2 (uk) 2018-04-25
JP2015521618A (ja) 2015-07-30
EA027981B1 (ru) 2017-09-29
EA201590078A1 (ru) 2015-06-30
KR20150034192A (ko) 2015-04-02
CN104470538B (zh) 2017-12-22

Similar Documents

Publication Publication Date Title
CU24238B1 (es) Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae
MX340541B (es) Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
WO2021226436A8 (en) Optimized nucleotide sequences encoding sars-cov-2 antigens
CL2019003264A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas. (divisional solicitud 201703151)
BR112012023852A2 (pt) vacinas recombinantes do vírus da língua azul e usos das mesmas
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
NZ708144A (en) Recombinant adenoviruses and use thereof
AR098256A1 (es) Vectores para expresión de antígenos asociados a próstata
MX364689B (es) Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer.
MX2014014668A (es) Vacuna.
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
PY1548374A (es) Vacunas de FMDV recombinante y usos de las mismas
CL2011003003A1 (es) Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria.
CL2017000625A1 (es) Composiciones de glicoconjugado inmunogénico/terapéutico y sus usos
BR112015000585A8 (pt) método para preparar uma cepa mutante de mycoplasma hyopneumoniae, vetores, cepa mutante, vacina, kit de vacinação e usos do vetor e da cepa mutante
ECSP11011327A (es) Derivados de aminotetralina, composiciones farmacéuticas que los contienen, y sus usos en terapia
GB2539148A (en) Vaccine compositions
MX2016001695A (es) Composiciones inmunogenas de combinacion.
MX363149B (es) Vacunas de nucleoproteina de la influenza.
PH12015502844B1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
PH12015502005B1 (en) New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
MX2017015482A (es) Peptidos lipidados resistentes a proteasas.
NZ704188A (en) Attenuated swine influenza vaccines and methods of making and use thereof
MX357431B (es) Vacuna contra garrapatas rhipicephalus.
AR087811A1 (es) Vacuna contra el staphylococcus aureus